Sequence 29 from Patent US 5831002

General Information


DRACP ID  DRACP01548

Peptide Name   Sequence 29 from Patent US 5831002

Sequence  XVPP

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic construct

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  X=Xaa

Chiral  L



Physicochemical Information


Formula  C15H23N3O3

Absent amino acids  ACDEFGHIKLMNQRSTWY

Common amino acids  P

Mass  45705

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  404

Hydrophobicity  25

Aliphatic Index  72.5

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 5831002 A

Patent Title  Antitumor peptides.

Other Iinformation  Granted Patent Family: 92s / 92ex; Family Jurisdictions: AU, BR, EP, DK, RO, KR, SI, JP, CA, HU, CZ, DE, NZ, AT, NO, AR, MX, WO, SK, IL, CO, BG, MY, UA, PL, TR, ES, CN, PT, HR, TW, ZA, US; Legal Status: Expired; Application No: 47245395; Filed:Jun 7, 1995; Published: Nov 3, 1998; Earliest Priority: May 20, 1992; Granted: Nov 3, 1998

Other Published ID  CA2219818A1  CA2219818C  CA2219819A1  CA2219819C  CN1182153C  CN1182154C  CN1187198A  CN1187199A  DE69623472D1  DE69623472T2  DE69623992D1  DE69623992 




DRACP is developed by Dr.Zheng's team.